Search results for "Gain"

showing 10 items of 625 documents

Development of a New Nordic Diet score and its association with gestational weight gain and fetal growth - A study performed in the Norwegian Mother …

2014

AbstractObjectiveTo construct a diet score for assessing degree of adherence to a healthy and environmentally friendly New Nordic Diet (NND) and to investigate its association with adequacy of gestational weight gain and fetal growth in a large prospective birth cohort.DesignMain exposure was NND adherence, categorized as low, medium or high adherence. Main outcomes were adequacy of gestational weight gain, described as inadequate, optimal or excessive according to the 2009 Institute of Medicine guidelines, and fetal growth, categorized as being small, appropriate or large for gestational age. Associations of NND adherence with gestational weight gain and fetal growth were estimated with mu…

AdultMaleRiskPediatricsmedicine.medical_specialtyAdolescentVDP::Gynekologi og obstetrikk: 756Birth weightMedicine (miscellaneous)Health PromotionWeight GainModels BiologicalNutrition PolicyCohort StudiesFetal DevelopmentNutrient densityYoung AdultPregnancymedicineHumansProspective StudiesProspective cohort studyVDP::Gynaecology and obstetrics: 756PregnancyFetal Growth RetardationNutrition and DieteticsNorwaybusiness.industryObstetricsInfant NewbornPublic Health Environmental and Occupational HealthGestational ageMaternal Nutritional Physiological PhenomenaOverweightmedicine.diseaseDietPregnancy ComplicationsPatient ComplianceSmall for gestational ageFemalemedicine.symptombusinessWeight gainFollow-Up StudiesCohort study
researchProduct

The Consumption of Fast Food Favors Weight Increase in Young Hellenic Navy Personnel: A 10-Year Follow-Up Study

2020

Introduction: Dietary habits and physical exercise have independently been recognized as important contributors to weight loss. However, the relative effect of diet and exercise on body weight is s...

AdultMaleTime FactorsNavy PersonnelEndocrinology Diabetes and MetabolismPhysical exerciseWeight GainBody weightRisk AssessmentBody Mass IndexRisk FactorsWeight lossEnvironmental healthInternal MedicineHumansMedicineObesityProspective StudiesExerciseConsumption (economics)Greecebusiness.industry10 year follow upFeeding Behaviormedicine.diseaseObesityMilitary PersonnelFast FoodsFemalemedicine.symptomEnergy IntakebusinessNutritive ValueBody mass indexFollow-Up StudiesMetabolic Syndrome and Related Disorders
researchProduct

Long-Term Drug Misuse Increases the Risk of Cognitive Dysfunctions in Intimate Partner Violence Perpetrators: Key Intervention Targets for Reducing D…

2019

Intimate partner violence against women (IPVAW) is a major public health problem, with an important mortality rate in women across the world. In this regard, it has been well-established that drug misuse explains (at least in part) an increased risk of IPVAW perpetration. Even though alcohol is the most widely studied drug underlying IPVAW, other drugs, such as cannabis and cocaine also seem to be significant indicators of this type of violence. Nonetheless, little is known about mediators, such as cognitive domains that facilitate proneness to violence after drug consumption. Therefore, the primary objective of the present study was to compare drug misuse patterns and cognitive performance…

AdultMalecognition050103 clinical psychologymedicine.medical_specialtydrug misuseHealth Toxicology and MutagenesisPoison controllcsh:MedicineIntimate Partner ViolenceArticleHeroinDrug Users03 medical and health sciences0302 clinical medicineIntervention (counseling)Injury preventionJuvenile delinquencyMedicineHumans0501 psychology and cognitive sciencesCognitive Dysfunction030212 general & internal medicineintimate partner violence against womenPsychiatrybiologydecision-making processbusiness.industry05 social scienceslcsh:RPublic Health Environmental and Occupational HealthreoffendingHuman factors and ergonomicsMiddle AgedDones maltractadesbiology.organism_classificationDomestic violenceFemaleCannabisDroguesbusinessmedicine.drug
researchProduct

Outcome of enzyme replacement therapy in patients with Gaucher disease type I. The Romanian experience

2007

This study reports the first evaluation of therapeutic response in Romanian patients with Gaucher disease type I, after therapy with Cerezyme recently became available in our country.24 patients (11-50 years) received Cerezyme 20-60 U/kg every two weeks for at least 18 months. Haemoglobin, platelet count, volume of the liver and spleen, plasma chitotriosidase and the severity score were assessed every 6 months; skeletal radiography and osteodensitometry were also monitored.Eleven patients were splenectomized before start of therapy. Eight patients had anaemia (mean haemoglobin 9.4 g/dl) and 14 patients, of whom 13 were without splenectomy, had thrombocytopenia (mean 65,692/mm3). Haemoglobin…

AdultMalecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyPediatricsTime FactorsAdolescentBone diseasemedicine.medical_treatmentDiseaseWeight GainSeverity of Illness IndexHemoglobinsGeneticsmedicineHumansIn patientChildGenetics (clinical)ChemotherapyGaucher DiseasePlatelet CountRomaniabusiness.industryLiver DiseasesRomaniannutritional and metabolic diseasesAnemiaEnzyme replacement therapyMiddle Agedmedicine.diseaseCombined Modality TherapyThrombocytopeniaRecombinant Proteinslanguage.human_languageSurgeryHexosaminidasesTreatment OutcomeSplenomegalyQuality of LifeSplenectomylanguageGlucosylceramidaseFemaleBone DiseasesbusinessFollow-Up StudiesJournal of Inherited Metabolic Disease
researchProduct

Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a dec…

2022

Objectives: The aim of this study was to assess the incidence of being overweight and metabolic syndrome (MS) among people living with HIV (PHIV) in three different cross-sectional studies conducted over three different periods: 2005, 2011 and 2015. Methods: This was a multi-centre, nationwide study. Data were collected in three studies from the CISAI group - SIMOne, HIV-HY and STOPSHIV - and included a total of 3014 PHIV. Logistic regression [odds ratio (OR), 95% confidence interval (CI)] was used to account for age and gender difference among three groups when comparing MS prevalence and being overweight; potential confounders were accounted for by including them in the regression equatio…

AdultMaledyslipidaemiaantiretroviral therapyHIV InfectionsOverweightLogistic regressionBody Mass IndexCohort StudiesPrevalencemedicineoverweightHumansPharmacology (medical)Metabolic Syndromebusiness.industryHealth PolicyIncidence (epidemiology)Body WeightHIVweight gainOdds ratioMiddle Agedmedicine.diseaseConfidence intervalHIV; antiretroviral therapy; dyslipidaemia; metabolic syndrome; overweight; weight gainCross-Sectional StudiesInfectious Diseasesweight gain.Metabolic syndromemedicine.symptombusinessWeight gainDemographyCohort studyHIV Medicine
researchProduct

Long-term effects of a multidisciplinary treatment of uncomplicated obesity on carotid intima-media thickness

2011

Obesity is associated with well-known cardiovascular risk factors and a lower life expectancy. This study investigated whether nonoperative nutritional treatment of obesity without comorbidities influenced the carotid intima-media thickness (c-IMT) in the long run. Fifty-four subjects of an original cohort of 251 subjects were re-evaluated 10 years after a medical nutritional treatment (MNT) with cognitive-behavioral approach for uncomplicated obesity. Forty subjects were classified as failure (10-year body weight change >0.5 kg) and 14 (body weight change ≤0.5 kg) as a success of the MNT. Ten years after MNT, c-IMT significantly increased (0.06 ± 0.02 mm; P = 0.004) in the failure group an…

AdultMalemedicine.medical_specialtyAdolescentDiet ReducingCarotid Artery CommonEndocrinology Diabetes and MetabolismMedicine (miscellaneous)Coronary Artery DiseaseWeight GainSeverity of Illness IndexBody Mass IndexCohort StudiesYoung AdultEndocrinologyBehavior TherapyRisk FactorsInternal medicineSeverity of illnessmedicineHumansSingle-Blind MethodObesityAgedNutrition and Dieteticsbusiness.industryAge FactorsMiddle AgedStepwise regressionmedicine.diseaseObesitySurgeryItalyIntima-media thicknessobesity treatment carotid intima-media thicknessCohortFemalemedicine.symptomTunica IntimaTunica MediabusinessWeight gainBody mass indexFollow-Up StudiesCohort study
researchProduct

Body mass index (BMI) in major depressive disorder and its effects on depressive symptomatology and antidepressant response

2019

Obesity is one of the most prevalent somatic comorbidities of Major Depressive Disorder (MDD). We aimed to investigate the relationship between body mass index (BMI) and MDD, the symptomatology of the disorder as well as the outcome of antidepressant treatment.Early medication change (EMC) trial participants with BMI measurement (n = 811) were categorized according to WHO-criteria in normal or low weight (BMI  25), overweight (25- 30), and obese (≥30). Depression severity and BMI was assessed in weekly intervals up to 8 weeks. BMI at baseline and course of BMI during the study were investigated in linear regression models as possible moderators of therapy response. Possible moderators such …

AdultMalemedicine.medical_specialtyComorbidityOverweightWeight GainBody Mass IndexDepressive symptomatology03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansObesityDepression (differential diagnoses)Depressive Disorder Majorbusiness.industryMiddle Agedmedicine.diseaseObesityAntidepressive Agents030227 psychiatryPsychiatry and Mental healthClinical PsychologyAntidepressantMajor depressive disorderFemalemedicine.symptombusinessWeight gainBody mass index030217 neurology & neurosurgeryJournal of Affective Disorders
researchProduct

Altered endocannabinoid-dynamics in craniopharyngioma patients and their association with HPA-axis disturbances.

2021

Objective Patients with craniopharyngioma (CP) frequently suffer from morbid obesity. Endocannabinoids (ECs) are involved in weight gain and rewarding behavior but have not been investigated in this context. Design Cross-sectional single-center study. Methods Eighteen patients with CP and 16 age- and sex-matched controls were included. Differences in endocannabinoids (2-arachidonoylglycerol (2-AG) and N-arachidonoylethanolamine (AEA)) and endocannabinoid-like molecules (oleoyl ethanolamide (OEA), palmitoylethanolamide (PEA), and arachidonic acid (AA) were measured at baseline and following endurance exercise. We further explored ECs-dynamics in relation to markers of HPA-axis activity (ACT…

AdultMalemedicine.medical_specialtyHypothalamo-Hypophyseal SystemHydrocortisonePolyunsaturated AlkamidesEndocrinology Diabetes and MetabolismHypothalamusContext (language use)Oleic AcidsArachidonic AcidsGlycerideschemistry.chemical_compoundCraniopharyngiomaYoung AdultEndocrinologyCopeptinAdrenocorticotropic HormoneEndurance trainingInternal medicinemedicineEthanolamideHumansPituitary NeoplasmsExerciseArachidonic Acidbusiness.industryGlycopeptidesGeneral MedicineMiddle Agedmedicine.diseaseEndocannabinoid systemCraniopharyngiomaEndurance TrainingEndocrinologyCross-Sectional StudieschemistryCase-Control StudiesArachidonic acidFemalemedicine.symptombusinessWeight gainEndocannabinoidsEuropean journal of endocrinology
researchProduct

Associations between long-term physical activity, waist circumference and weight gain: a 30-year longitudinal twin study.

2007

Background and objective: Physical activity level and obesity are both partly determined by genes and childhood environment. To determine the associations between long-term leisure-time physical activity, weight gain and waist circumference and whether these are independent of genes and childhood effects. Design and subjects: The study design is a 30-year follow-up twin study in Finland. For this study, 146 twin pairs were comprehensively identified from the large Finnish Twin Cohort. These twin pairs were discordant for both intensity and volume of leisure physical activity in 1975 and 1981 and were healthy in 1981. At follow-up in 2005, both members of 89 pairs were alive and participated…

AdultMalemedicine.medical_specialtyLongitudinal studyWaistAdolescentEndocrinology Diabetes and MetabolismDizygotic twinHealth BehaviorMedicine (miscellaneous)physical activity030209 endocrinology & metabolismMotor ActivityliikuntaWeight Gain03 medical and health sciences0302 clinical medicineInternal medicineTwins DizygoticmedicineBody SizeHumansObesity030212 general & internal medicineExerciseFinlandNutrition and Dieteticsbusiness.industryTwins MonozygoticMiddle AgedCircumferenceTwin studyPhysical activity levelEndocrinologylihavuusFemalemedicine.symptomEpidemiologic MethodsbusinessWeight gainBody mass indexDemography
researchProduct

BODY MASS INDEX DOES NOT CHANGE BEFORE PARKINSON'S DISEASE ONSET.

2008

Background and purpose:  Previous studies on the association between Parkinson’s disease (PD) and body mass index (BMI) have reported conflicting results. We investigated the relationship between PD and BMI by a case–control study. Methods:  PD patients were randomly matched to healthy individuals by sex and age. BMI distribution in cases has been compared with BMI of controls and odd ratios (ORs) with 95% CI were calculated. Results:  We included 318 PD patients and 318 controls. We observed no association between PD and BMI. BMI distribution in cases and controls was similar also when we adjusted for diabetes, hypercholesterolemia and the time elapsed between PD onset and the interview (O…

AdultMalemedicine.medical_specialtyParkinson's diseaseHypercholesterolemiaPopulationComorbidityWeight GainCoffeeBody Mass IndexRisk FactorsInternal medicineDiabetes mellitusWeight LossEpidemiologyDiabetes MellitusmedicineHumansObesityAge of OnseteducationAgedAged 80 and overHypertriglyceridemiaeducation.field_of_studybusiness.industrySmokingCase-control studynutritional and metabolic diseasesParkinson DiseaseMiddle AgedOverweightmedicine.diseaseNeurologyCase-Control StudiesHealthy individualsanthropometrical measures body mass index case–control study epidemiology Parkinson's disease risk factorsPhysical therapyFemaleSettore MED/26 - NeurologiaNeurology (clinical)businessBody mass index
researchProduct